Table 5.
Study | Methods | Reproducibility results |
---|---|---|
King et al. [34] | Repeated measurements | Intra-observer: CV = 1.2% and 1.4%, ICC = 0.987 and 0.983; inter-observer: CV = 2.5%, reliability coefficient = 0.983 |
19 ADPKD patients | ||
Bax et al. [22] | 3 repeated scans (2 successive + 7–21 days apart) | Inter-study CV = 17% (successive scans) and 23% (longer time interval) |
19 HVs | ||
Dambreville et al. [40] | 6 repeated scans (2 successive + 4 ones 1-week apart) | Inter-study RBF difference = 30.8 ± 3.5 mL/min (successive scans); CV = 10.6% (overall), CV = 9.0% (weekly interval), CV = 4.2% (successive scans) |
6 HVs | ||
Wentland et al. [20] | 2 repeated scans (n = 2) | Inter-study RBF difference = 14.0 ± 12.5% (2D PC-MRI), 15.1 ± 15.6% (4D PC-MRI) |
10 HVs | ||
Khatir et al. [15] | 2 repeated scans (1–2 weeks apart) | Inter-study CV = 8.3% (HVs) and 12.9% (CKD); ICC = 0.92 (HVs) and 0.78 (CKD) |
11 HVs and 9 CKD patients | ||
Keegan et al. [12] | 2 repeated scans + repeated measurements | RBF difference: 38.5 ± 20.0 mL/min (inter-observer), 17.9 ± 44.8 (inter-study, observer 1), 24.2 ± 59.0 (inter-study, observe R2) |
10 HVs | ||
Spithoven et al. [41] | Repeated measurements | Intra-observer: CV = 2.3%, ICC = 0.997 and 0.995; inter-observer: CV = 3.5%, ICC = 0.991 |
21 ADPKD patients | ||
Cox et al. [13] | 2–3 repeated scans | Inter-study CV = 14.4 ± 4.3%, ICC = 0.844 |
11 HVs | ||
Kline et al. [36] | 2 repeated scans (24–210 h apart) | Inter-study reproducibility: 10.1 ± 7.8% |
10 HVs |
PC, phase contrast; ICC, intraclass correlation coefficient; RBF, renal blood flow; HVs, healthy volunteers; ADPKD, autosomal dominant polycystic kidney disease; CKD, chronic kidney disease; CV, coefficient of variation; CCC, concordance correlation coefficient